U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 49

1.
Comparison of proximal and distal gastric neuroendocrine carcinoma based on SEER database
Lingjie Kong, Chaobiao Yan, Shijiao Nie, Haijuan Jin, XiaoWen Li
Sci Rep. 2024; 14: 25956. Published online 2024 Oct 29. doi: 10.1038/s41598-024-76689-z
PMCID:
PMC11522417
AbstractArticlePDF–4.0M
2.
Gastric Neuroendocrine Carcinoma Presenting as Ascites in a Young Female
Yogesh Bade, Prashant Gopal, Amol S Dahale, Abhijeet Karad
Cureus. 2024 Jul; 16(7): e64964. Published online 2024 Jul 19. doi: 10.7759/cureus.64964
PMCID:
PMC11333027
AbstractArticlePDF–3.3M
3.
A gastric neuroendocrine carcinoma with good prognosis after chemotherapy combined with immunotherapy: A case report (CARE-compliant)
Yuanzheng Zhao, Rong Yang, Hongxia Lu
Medicine (Baltimore) 2023 Dec 15; 102(50): e36568. Published online 2023 Dec 15. doi: 10.1097/MD.0000000000036568
PMCID:
PMC10727576
AbstractArticlePDF–678K
4.
Equivalent Survival between Gastric Large-Cell Neuroendocrine Carcinoma and Gastric Small-Cell Neuroendocrine Carcinoma
Zefeng Li, Hu Ren, Xiaojie Zhang, Chongyuan Sun, He Fei, Zheng Li, Chunguang Guo, Susheng Shi, Yingtai Chen, Dongbing Zhao
J Clin Med. 2023 Sep; 12(18): 6039. Published online 2023 Sep 18. doi: 10.3390/jcm12186039
PMCID:
PMC10531653
AbstractArticlePDF–1.4M
5.
Evaluation of the safety and immunological effects of Bacillus Calmette–Guérin in combination with checkpoint inhibitor therapy in a patient with neuroendocrine carcinoma: a case report
Konstantin Föhse, Priya A. Debisarun, Gizem Kilic, Joyce M. van Dodewaard-de Jong, Mihai G. Netea
J Med Case Rep. 2023; 17: 377. Published online 2023 Sep 4. doi: 10.1186/s13256-023-04117-3
PMCID:
PMC10476294
AbstractArticlePDF–1.4M
6.
Gastric neuroendocrine carcinoma presenting complete durable response by nivolumab treatment for multiple metastases and radiotherapy to oligoprogressive metastasis
Yusuke Seyama, Takeshi Yamada, Hirosumi Suzuki, Satoshi Fukuda, Miki Tsuji, Yusuke Niisato, Suguru Hirose, Yoshiyuki Yamamoto, Toshikazu Moriwaki, Ichinosuke Hyodo
Int Cancer Conf J. 2023 Oct; 12(4): 268–273. Published online 2023 May 12. doi: 10.1007/s13691-023-00611-z
PMCID:
PMC10421835
AbstractArticlePDF–1.1M
7.
Value of a preoperative prognostic nutritional index for the prognostic evaluation of gastric neuroendocrine carcinoma patients
Jiangpeng Wei, Ju Lu, Hanxiang Jia, Xisheng Yang, Xin Guo, Jinqiang Liu, Xiaohua Li
Front Nutr. 2023; 10: 1043550. Published online 2023 Jul 24. doi: 10.3389/fnut.2023.1043550
PMCID:
PMC10406506
AbstractArticlePDF–850K
8.
Optimal postoperative surveillance strategies for cancer survivors with gastric neuroendocrine carcinoma based on individual risk: a multicenter real-world cohort study
Bin-bin Xu, Xin-Yang He, Yan-bing Zhou, Qing-liang He, Yan-tao Tian, Han-kun Hao, Xian-tu Qiu, Li-xin Jiang, Gang Zhao, Zhi li, Yan-chang Xu, Wei-hua Fu, Fang-qin Xue, Shu-liang Li, Ze-kuan Xu, Zheng-gang Zhu, Yong Li, En Li, Jin-ping Chen, Hong-lang Li, Li-sheng Cai, Dong Wu, Ping Li, Chao-hui Zheng, Jian-wei Xie, Jun Lu, Chang-Ming Huang
Int J Surg. 2023 Jun; 109(6): 1668–1676. Published online 2023 Apr 20. doi: 10.1097/JS9.0000000000000401
PMCID:
PMC10389463
AbstractArticlePDF–673K
9.
A novel nomogram and risk stratification system predicting the cancer-specific survival of patients with gastric neuroendocrine carcinoma: a study based on SEER database and external validation
Xue Song, Yangyang Xie, Yafang Lou
BMC Gastroenterol. 2023; 23: 238. Published online 2023 Jul 14. doi: 10.1186/s12876-023-02875-4
PMCID:
PMC10347809
AbstractArticlePDF–2.9M
10.
De-escalating chemotherapy for stage I–II gastric neuroendocrine carcinoma? A real-world competing risk analysis
Danwei Du, Yangyang Xie, Xiaowen Li, Zhongkai Ni, Jinbo Shi, Hai Huang
World J Surg Oncol. 2023; 21: 142. Published online 2023 May 6. doi: 10.1186/s12957-023-03029-2
PMCID:
PMC10163728
AbstractArticlePDF–2.9M
11.
Novel staging for gastric neuroendocrine neoplasms by incorporating the WHO grading into the TNM staging system
Rihong Zhang, Yu Guo, Youliang Wang, Li Hu, Cheng Fang, Yujie Yang, Xianqi Yang, Luohai Chen, Jie Chen, Wei Wang, Xiaowei Sun
Cancer Med. 2023 Mar; 12(6): 6623–6636. Published online 2022 Nov 16. doi: 10.1002/cam4.5437
PMCID:
PMC10067116
AbstractArticlePDF–5.6M
12.
Differences in clinicopathology and prognosis between gastroesophageal junctional and gastric non-cardiac neuroendocrine carcinomas: a retrospective comparison study of consecutive 56 cases from a single institution in China
Yuqing Cheng, Xinwen Zhang, Xiaoli Zhou, Kequn Xu, Min Lin, Qin Huang
Am J Cancer Res. 2022; 12(10): 4737–4750. Published online 2022 Oct 15.
PMCID:
PMC9641387
AbstractArticlePDF–1.5M
13.
Gastric neuroendocrine carcinoma (carcinoid) in a ferret (Mustela putorius furo)
Teresa Bousquet, Maria Bravo-Araya, Jennifer L. Davies
Can Vet J. 2022 Nov; 63(11): 1109–1113.
PMCID:
PMC9559030
AbstractArticlePDF–3.4M
14.
RUNDC3A/SNAP25/Akt signaling mediates tumor progression and chemoresistance in gastric neuroendocrine carcinoma
Ziqi Lin, Hang Fai Kwok
Cell Death Dis. 2022 Oct; 13(10): 840. Published online 2022 Oct 1. doi: 10.1038/s41419-022-05294-7
PMCID:
PMC9526696
AbstractArticlePDF–468K
15.
Spleen metastases secondary to gastric neuroendocrine carcinoma: case report
Sahar Nasr, Amal Khsiba, Moufida Mahmoudi, Asma Ben Mohamed, Mehdi Bouasida, Lamine Hamzaoui
Pan Afr Med J. 2022; 42: 131. Published online 2022 Jun 16. doi: 10.11604/pamj.2022.42.131.34091
PMCID:
PMC9430885
AbstractArticlePDF–761K
16.
Resection of the Primary Tumor Improves the Survival of Patients With Stage IV Gastric Neuroendocrine Carcinoma
Zefeng Li, Hu Ren, Tongbo Wang, Xiaojie Zhang, Lulu Zhao, Chongyuan Sun, Penghui Niu, Chunguang Guo, Yingtai Chen, Dongbing Zhao
Front Oncol. 2022; 12: 930491. Published online 2022 Jul 14. doi: 10.3389/fonc.2022.930491
PMCID:
PMC9329560
AbstractArticlePDF–1.4M
17.
Better Prognosis of Gastric Neuroendocrine Carcinoma Than Gastric Adenocarcinoma among Whites in the United States: A Propensity Score Matching Analysis Based on SEER
Zefeng Li, Hu Ren, Lulu Zhao, Xiaojie Zhang, Tongbo Wang, Chongyuan Sun, Penghui Niu, Wanqing Wang, He Fei, Chunguang Guo, Yingtai Chen, Dongbing Zhao
Curr Oncol. 2022 Jul; 29(7): 4879–4892. Published online 2022 Jul 11. doi: 10.3390/curroncol29070387
PMCID:
PMC9323980
AbstractArticlePDF–1.5M
18.
Risk factors for metastasis and survival of patients with T1 gastric neuroendocrine carcinoma treated with endoscopic therapy versus surgical resection
Hua Ye, Yuan Yuan, Ping Chen, Qi Zheng
Surg Endosc. 2022; 36(8): 6162–6169. Published online 2022 May 3. doi: 10.1007/s00464-022-09190-1
PMCID:
PMC9283353
AbstractArticlePDF–868K
19.
RUNDC3A regulates SNAP25-mediated chemotherapy resistance by binding AKT in gastric neuroendocrine carcinoma (GNEC)
Pengchen Chen, Wei Wang, Sin Wa Wong, Junnan Li, Qiushaung Wu, Shu-Dong Zhang, Yao Lin, Hang Fai Kwok
Cell Death Discov. 2022; 8: 296. Published online 2022 Jun 25. doi: 10.1038/s41420-022-01084-4
PMCID:
PMC9233710
AbstractArticlePDF–8.0M
20.
Mixed large and small cell neuroendocrine carcinoma of the stomach: A case report and review of literature
Ze-Feng Li, Hai-Zhen Lu, Ying-Tai Chen, Xiao-Feng Bai, Tong-Bo Wang, He Fei, Dong-Bing Zhao
World J Clin Cases. 2022 Jun 6; 10(16): 5502–5509. Published online 2022 Jun 6. doi: 10.12998/wjcc.v10.i16.5502
PMCID:
PMC9210888
AbstractArticlePDF–12M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center